Financhill
Buy
64

ISRG Quote, Financials, Valuation and Earnings

Last price:
$524.82
Seasonality move :
2.7%
Day range:
$516.18 - $530.97
52-week range:
$320.26 - $556.23
Dividend yield:
0%
P/E ratio:
84.31x
P/S ratio:
24.04x
P/B ratio:
11.99x
Volume:
3.9M
Avg. volume:
1.4M
1-year change:
61.15%
Market cap:
$186.8B
Revenue:
$7.1B
EPS (TTM):
$6.22

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ISRG
Intuitive Surgical
$2B $1.64 14.07% 3.69% $556.42
ABT
Abbott Laboratories
$10.6B $1.20 7.79% 47.49% $130.20
BDX
Becton Dickinson &
$5.4B $3.77 8.75% 211.95% --
GKOS
Glaukos
$91.5M -$0.48 22.29% -49.34% --
PRCT
PROCEPT BioRobotics
$53.2M -$0.49 53.23% -37.41% $102.75
SYK
Stryker
$5.4B $2.77 9.42% 29.99% $406.60
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ISRG
Intuitive Surgical
$524.43 $556.42 $186.8B 84.31x $0.00 0% 24.04x
ABT
Abbott Laboratories
$114.23 $130.20 $198.1B 34.72x $0.55 1.93% 4.85x
BDX
Becton Dickinson &
$227.68 -- $65.8B 38.33x $1.04 1.71% 3.28x
GKOS
Glaukos
$150.88 -- $8.3B -- $0.00 0% 21.38x
PRCT
PROCEPT BioRobotics
$81.17 $102.75 $4.4B -- $0.00 0% 20.84x
SYK
Stryker
$364.60 $406.60 $139B 39.08x $0.80 0.88% 6.39x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ISRG
Intuitive Surgical
-- 1.253 -- 3.29x
ABT
Abbott Laboratories
27.35% 0.747 8.05% 1.14x
BDX
Becton Dickinson &
43.72% 0.356 28.85% 0.58x
GKOS
Glaukos
7.83% 1.181 0.79% 4.45x
PRCT
PROCEPT BioRobotics
17.58% 0.117 1.23% 4.95x
SYK
Stryker
43.45% 1.032 11.46% 1.10x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ISRG
Intuitive Surgical
$1.4B $577.3M 15.9% 15.9% 28.33% $458.6M
ABT
Abbott Laboratories
$5.9B $1.9B 10.69% 14.78% 19.58% $2.1B
BDX
Becton Dickinson &
$2.5B $793M 3.91% 6.63% 12.31% $882M
GKOS
Glaukos
$74.1M -$24.7M -20.29% -27.46% -20.24% -$11M
PRCT
PROCEPT BioRobotics
$36.9M -$22.4M -31.39% -37.42% -33.98% -$19M
SYK
Stryker
$3.5B $1.1B 11.09% 18.78% 19.75% $1.3B

Intuitive Surgical vs. Competitors

  • Which has Higher Returns ISRG or ABT?

    Abbott Laboratories has a net margin of 27.73% compared to Intuitive Surgical's net margin of 15.48%. Intuitive Surgical's return on equity of 15.9% beat Abbott Laboratories's return on equity of 14.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    67.41% $1.56 $15.7B
    ABT
    Abbott Laboratories
    55.83% $0.94 $55B
  • What do Analysts Say About ISRG or ABT?

    Intuitive Surgical has a consensus price target of $556.42, signalling upside risk potential of 6.1%. On the other hand Abbott Laboratories has an analysts' consensus of $130.20 which suggests that it could grow by 13.99%. Given that Abbott Laboratories has higher upside potential than Intuitive Surgical, analysts believe Abbott Laboratories is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 8 1
    ABT
    Abbott Laboratories
    13 5 0
  • Is ISRG or ABT More Risky?

    Intuitive Surgical has a beta of 1.383, which suggesting that the stock is 38.272% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.271%.

  • Which is a Better Dividend Stock ISRG or ABT?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.93% to investors and pays a quarterly dividend of $0.55 per share. Intuitive Surgical pays -- of its earnings as a dividend. Abbott Laboratories pays out 62.14% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or ABT?

    Intuitive Surgical quarterly revenues are $2B, which are smaller than Abbott Laboratories quarterly revenues of $10.6B. Intuitive Surgical's net income of $565.1M is lower than Abbott Laboratories's net income of $1.6B. Notably, Intuitive Surgical's price-to-earnings ratio is 84.31x while Abbott Laboratories's PE ratio is 34.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 24.04x versus 4.85x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    24.04x 84.31x $2B $565.1M
    ABT
    Abbott Laboratories
    4.85x 34.72x $10.6B $1.6B
  • Which has Higher Returns ISRG or BDX?

    Becton Dickinson & has a net margin of 27.73% compared to Intuitive Surgical's net margin of 7.36%. Intuitive Surgical's return on equity of 15.9% beat Becton Dickinson &'s return on equity of 6.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    67.41% $1.56 $15.7B
    BDX
    Becton Dickinson &
    45.74% $1.45 $46B
  • What do Analysts Say About ISRG or BDX?

    Intuitive Surgical has a consensus price target of $556.42, signalling upside risk potential of 6.1%. On the other hand Becton Dickinson & has an analysts' consensus of -- which suggests that it could grow by 22.99%. Given that Becton Dickinson & has higher upside potential than Intuitive Surgical, analysts believe Becton Dickinson & is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 8 1
    BDX
    Becton Dickinson &
    0 0 0
  • Is ISRG or BDX More Risky?

    Intuitive Surgical has a beta of 1.383, which suggesting that the stock is 38.272% more volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.408, suggesting its less volatile than the S&P 500 by 59.216%.

  • Which is a Better Dividend Stock ISRG or BDX?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton Dickinson & offers a yield of 1.71% to investors and pays a quarterly dividend of $1.04 per share. Intuitive Surgical pays -- of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or BDX?

    Intuitive Surgical quarterly revenues are $2B, which are smaller than Becton Dickinson & quarterly revenues of $5.4B. Intuitive Surgical's net income of $565.1M is higher than Becton Dickinson &'s net income of $400M. Notably, Intuitive Surgical's price-to-earnings ratio is 84.31x while Becton Dickinson &'s PE ratio is 38.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 24.04x versus 3.28x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    24.04x 84.31x $2B $565.1M
    BDX
    Becton Dickinson &
    3.28x 38.33x $5.4B $400M
  • Which has Higher Returns ISRG or GKOS?

    Glaukos has a net margin of 27.73% compared to Intuitive Surgical's net margin of -22.15%. Intuitive Surgical's return on equity of 15.9% beat Glaukos's return on equity of -27.46%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    67.41% $1.56 $15.7B
    GKOS
    Glaukos
    76.64% -$0.39 $725.3M
  • What do Analysts Say About ISRG or GKOS?

    Intuitive Surgical has a consensus price target of $556.42, signalling upside risk potential of 6.1%. On the other hand Glaukos has an analysts' consensus of -- which suggests that it could fall by -2.41%. Given that Intuitive Surgical has higher upside potential than Glaukos, analysts believe Intuitive Surgical is more attractive than Glaukos.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 8 1
    GKOS
    Glaukos
    0 0 0
  • Is ISRG or GKOS More Risky?

    Intuitive Surgical has a beta of 1.383, which suggesting that the stock is 38.272% more volatile than S&P 500. In comparison Glaukos has a beta of 1.034, suggesting its more volatile than the S&P 500 by 3.395%.

  • Which is a Better Dividend Stock ISRG or GKOS?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Glaukos offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Glaukos pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ISRG or GKOS?

    Intuitive Surgical quarterly revenues are $2B, which are larger than Glaukos quarterly revenues of $96.7M. Intuitive Surgical's net income of $565.1M is higher than Glaukos's net income of -$21.4M. Notably, Intuitive Surgical's price-to-earnings ratio is 84.31x while Glaukos's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 24.04x versus 21.38x for Glaukos. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    24.04x 84.31x $2B $565.1M
    GKOS
    Glaukos
    21.38x -- $96.7M -$21.4M
  • Which has Higher Returns ISRG or PRCT?

    PROCEPT BioRobotics has a net margin of 27.73% compared to Intuitive Surgical's net margin of -35.93%. Intuitive Surgical's return on equity of 15.9% beat PROCEPT BioRobotics's return on equity of -37.42%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    67.41% $1.56 $15.7B
    PRCT
    PROCEPT BioRobotics
    63.24% -$0.40 $292.7M
  • What do Analysts Say About ISRG or PRCT?

    Intuitive Surgical has a consensus price target of $556.42, signalling upside risk potential of 6.1%. On the other hand PROCEPT BioRobotics has an analysts' consensus of $102.75 which suggests that it could grow by 26.59%. Given that PROCEPT BioRobotics has higher upside potential than Intuitive Surgical, analysts believe PROCEPT BioRobotics is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 8 1
    PRCT
    PROCEPT BioRobotics
    6 2 0
  • Is ISRG or PRCT More Risky?

    Intuitive Surgical has a beta of 1.383, which suggesting that the stock is 38.272% more volatile than S&P 500. In comparison PROCEPT BioRobotics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ISRG or PRCT?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PROCEPT BioRobotics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. PROCEPT BioRobotics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ISRG or PRCT?

    Intuitive Surgical quarterly revenues are $2B, which are larger than PROCEPT BioRobotics quarterly revenues of $58.4M. Intuitive Surgical's net income of $565.1M is higher than PROCEPT BioRobotics's net income of -$21M. Notably, Intuitive Surgical's price-to-earnings ratio is 84.31x while PROCEPT BioRobotics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 24.04x versus 20.84x for PROCEPT BioRobotics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    24.04x 84.31x $2B $565.1M
    PRCT
    PROCEPT BioRobotics
    20.84x -- $58.4M -$21M
  • Which has Higher Returns ISRG or SYK?

    Stryker has a net margin of 27.73% compared to Intuitive Surgical's net margin of 15.18%. Intuitive Surgical's return on equity of 15.9% beat Stryker's return on equity of 18.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    67.41% $1.56 $15.7B
    SYK
    Stryker
    64.02% $2.16 $35.6B
  • What do Analysts Say About ISRG or SYK?

    Intuitive Surgical has a consensus price target of $556.42, signalling upside risk potential of 6.1%. On the other hand Stryker has an analysts' consensus of $406.60 which suggests that it could grow by 11.52%. Given that Stryker has higher upside potential than Intuitive Surgical, analysts believe Stryker is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 8 1
    SYK
    Stryker
    13 9 0
  • Is ISRG or SYK More Risky?

    Intuitive Surgical has a beta of 1.383, which suggesting that the stock is 38.272% more volatile than S&P 500. In comparison Stryker has a beta of 0.938, suggesting its less volatile than the S&P 500 by 6.217%.

  • Which is a Better Dividend Stock ISRG or SYK?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stryker offers a yield of 0.88% to investors and pays a quarterly dividend of $0.80 per share. Intuitive Surgical pays -- of its earnings as a dividend. Stryker pays out 35.99% of its earnings as a dividend. Stryker's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or SYK?

    Intuitive Surgical quarterly revenues are $2B, which are smaller than Stryker quarterly revenues of $5.5B. Intuitive Surgical's net income of $565.1M is lower than Stryker's net income of $834M. Notably, Intuitive Surgical's price-to-earnings ratio is 84.31x while Stryker's PE ratio is 39.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 24.04x versus 6.39x for Stryker. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    24.04x 84.31x $2B $565.1M
    SYK
    Stryker
    6.39x 39.08x $5.5B $834M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock